IMA · ImageneBio, Inc.
$5.51
-0.10 (-1.78%)
At close · Aug 21
Market Cap
$64.36M
Shares
11.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.51
Open$6.09
Day$5.51–6.21
52W close$4.55–14.23
Avg vol 30d11K
Short int385K · 3.4% float · 29.6d
Short vol56%
Last earningsMay 15, 2026
DataJul 2025–Aug 2026
Filing10-Q · Aug 5
Raw chart and full-history price indicators begin at the captured split on Jul 28, 2025; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
−5%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
10%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−14%
trailing
YTD return
−20%
this year
Relative strength
−25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-10% holders QoQ · +4 funds added
Insider flow
Distributing
Net -$17.3K over 90 days · 100% sells
Short interest
Falling
3.39% of float · ▼ -2.3% MoM · 29.6 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
35 holders — mid 1-yr range
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
−77%
Y/Y
EPS growth
+56%
Y/Y
Free cash flow
$-48.3M
Balance sheet
$94.5M
net cash
Quant / Vol
risk profile
Volatility
71%
annualized · 1-yr
Max drawdown
−68%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
−5%
Neutral
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
10%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-10% holders QoQ · +4 funds added
Insider flow
Distributing
Net -$17.3K over 90 days · 100% sells
Short interest
Falling
3.39% of float · ▼ -2.3% MoM · 29.6 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
35 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $5
Now $6 · 10%
Range high $14
vs 200-day avg -11%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMA
this stock
ImageneBio, Inc.
|
$64.36M | -20.1% | -77.1% | — | 3.4% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Jul 28, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMA | -5.7% | -1.4% | -13.5% | -0.5% | -20.1% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -4.3% | -5.1% | -25.1% | -3.0% | -32.4% |
Key facts
CIK
1835579
CUSIP
45175G207
13F (30d)
36 filings
36 filers
Visit website
Investor relations